Hi-Aspect

Name

Hi-Aspect

Legal name

Hi-Aspect

Website

https://hi-aspect.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Specialty Biomaterials

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Industrial Organic Chemicals (2860)

akta.pro primary industry

Hand & Body Care (Lotions, Creams, Body Oils) (CRADANAC)

akta.pro secondary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

Keywords

• Protein nanofibrils
• Biomaterial ingredients
• Personal care formulations
• Wound healing materials
• Skincare emulsifiers

Headquarters

HQ city

Lower Hutt

HQ country

New Zealand

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Product Sales: Sale of protein nanofibril-based materials and formulations to personal care, cosmetics, and wound care manufacturers
2. Technology Licensing: Licensing of proprietary protein nanofibril technology to partners for specific product applications
3. Formulation Partnerships: Partnership-based development and supply of customized formulations (e.g., Fibraspect300) to partner companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Hi-Aspect develops and commercialises proprietary protein nanofibril (PNF) materials derived from natural sources through a self-assembly process. The company partners with manufacturing and health companies to take these materials to market across personal care/cosmetics (as natural stabilisers, emulsifiers, and controlled-release vehicles) and wound care (as biological scaffolds for bioactive compound delivery). Their commercial product Fibraspect300 is currently used in the New Logic Acne range sold in New Zealand.

Product overview

Hi-Aspect is a platform technology company built around protein nanofibril (PNF) technology — a proprietary high surface area, insoluble protein material derived from natural sources via self-assembly. The core PNF technology serves as the foundational platform from which the company develops specific commercial products. The primary commercial product is Fibraspect300, currently used in the New Logic Acne range in New Zealand. Beyond Fibraspect300, Hi-Aspect offers two main product applications: Personal Care Gel (for skincare, cosmetics, and stabiliser/emulsifier replacement) and Wound Healing Gel (for wound care applications requiring bioactive compound delivery). All products leverage the tunable viscoelastic and biodegradable properties of the nanofibril platform.

Differentiator

Problem solved

Functional benefit

Brands

• Fibraspect300: Protein nanofibril technology currently used in the New Logic Acne range sold in New Zealand. A safe, natural gel that can replace traditional stabilisers and emulsifiers with an appealing silky feel and controlled release properties.

Products and services

• Fibraspect300
• Personal Care Gel
• Wound Healing Gel

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Callaghan InnovationcoreStrategic or Co-development Partner · 1 January 2015Government innovation agency providing research and development support. Hosted Hi-Aspect's R&D facility at their Gracefield site and provided ongoing support for the company's technology development.
• Plant and Food ResearchminorStrategic or Co-development Partner · 1 January 2015Research institution that collaborated with University of Canterbury on the original protein nanofibril technology invention with Professor Juliet Gerrard.
• University of AucklandminorStrategic or Co-development PartnerResearch partner providing scientific expertise and research capabilities to guide Hi-Aspect's research agendas.
• MacDiarmid InstituteminorStrategic or Co-development PartnerResearch partner providing scientific expertise in advanced materials and nanotechnology. Supported intern Manmeet Kaur and ongoing research collaboration.
• University of CanterburyminorStrategic or Co-development PartnerAcademic institution where Professor Juliet Gerrard invented the protein nanofibril technology with her team.
• New LogiccoreChannel Partner/ Reseller/ DistributorNew Zealand skincare company using Hi-Aspect's Fibraspect300 technology in their New Logic Acne range, demonstrating commercial application of the technology.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bolt Threads: California-based biotech producing protein-based fibers and ingredients (e.g., b-silk) for personal care and beauty. Peers with Hi-Aspect on using engineered/sourced proteins as a next-generation ingredient platform for cosmetics and skin care.
• Conagen: US biotech using fermentation to produce high-value protein and peptide ingredients for personal care, food, and pharma. Compares to Hi-Aspect as a platform protein producer with multi-vertical licensing and ingredient commercialization.
• Spiber: Japanese biotech that engineers and ferments protein-based materials (Brewed Protein) for apparel, automotive, and personal care. Highly comparable in that it leverages a proprietary protein self-assembly platform to address consumer-goods and adjacent markets.
• Amyris: Synthetic biology company producing fermentation-derived ingredients, including personal care and skincare actives. Comparable to Hi-Aspect as a biotech ingredient supplier moving up the value chain into branded personal care partnerships.
• GELITA: Global manufacturer of gelatin- and collagen-based proteins used in personal care, wound care, and medical applications. Strongly comparable to Hi-Aspect's protein-based gel platform serving both cosmetic and wound-healing use cases.
• Modern Meadow: US-based biotech producing protein-based and bio-fabricated materials for personal care and other applications. Directly comparable to Hi-Aspect as a startup commercializing proprietary protein-based materials into consumer end markets.

Broad incumbents

• Ashland: Global specialty ingredients supplier with significant personal care and pharmaceutical portfolios. Comparable as an incumbent offering bio-functional and rheology-modifying ingredients that overlap with Hi-Aspect's gel and emulsifier positioning.
• Lubrizol Life Science: Specialty chemicals business of Lubrizol serving personal care, pharmaceuticals, and medical devices. Comparable as a large incumbent with established wound-care and personal-care ingredient lines that Hi-Aspect would compete with as it scales.
• Evonik Industries: Global specialty chemicals company with a major personal care and life sciences division. Comparable as a large incumbent producing cosmetic ingredients and biomaterials that Hi-Aspect competes against in the skincare actives market.
• Croda International: Large global specialty ingredient supplier for personal care and pharmaceuticals. Comparable as the incumbent supplier of cosmetic emulsifiers and stabilizers that Hi-Aspect's Fibraspect300 is positioned to replace.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/hi_aspect
• LinkedInlinkedin.com/company/hi-aspect-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hi-Aspect